Sotalol is a sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. Among its listed roles, it functions as a beta-adrenergic antagonist, an anti-arrhythmia drug, an environmental contaminant and a xenobiotic. It belongs to the class of ethanolamines, a secondary amino compound, a secondary alcohol and a sulfonamide. It is the conjugate base of sotalol(1+). It is grouped under the following drug class(es): Beta blockers and QTc-prolonging agents. Its therapeutic use is listed as antiarrhythmics, antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include beta-Cardone, DL-Sotalol and Sotalolum. Its PubChem CID is 5253.
Sotalol
| CAS No | 3930-20-9 |
|---|---|
| Molecular Formula | C12H20N2O3S |
| Molecular Weight | 272.37 g/mol |
| Synonyms | N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sotalol is a sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group.
The listed CAS number is 3930-20-9.
The listed molecular formula is C12H20N2O3S.
The listed molecular weight is 272.37 g/mol.
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide.
The source lists beta-Cardone, DL-Sotalol and Sotalolum.